Terug
Dagbereik
€ 285,55
€ 299,30
52-Weeksbereik
€ 26,70
€ 356,00
Volume
489.921
50D / 200D Gem.
€ 312,99
/
€ 162,91
Vorige Slotkoers
€ 294,11
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (627 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -20,5 | 0,4 |
| P/B | 7,1 | 2,9 |
| ROE % | -45,8 | 3,7 |
| Net Margin % | — | 3,9 |
| Rev Growth 5Y % | — | 10,0 |
| D/E | 0,0 | 0,2 |
Koersdoel Analisten
Hold
€ 510,40
+73.2%
Low: € 83,00
High: € 843,00
Forward WPA
-€ 15,07
Omzet Sch.
6,4 M
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
€ 59,55
€ 10,48 – € 130,09
|
3,5 B | 5 |
| FY2029 |
€ 33,90
€ 5,97 – € 74,06
|
2,2 B | 11 |
| FY2028 |
€ 9,61
-€ 8,88 – € 31,39
|
1,1 B | 13 |
Belangrijkste Punten
Debt/Equity of 0,00 — conservative balance sheet
Negative free cash flow of -249,12M
Groei
Revenue Growth (5Y)
N/A
Revenue (1Y)-100,00%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-45,83%
ROIC-27,86%
Net MarginN/A
Op. MarginN/A
Veiligheid
Debt / Equity
0,00
Current Ratio10,22
Interest Coverage0,00
Waardering
P/E Ratio
-20,54
P/B Ratio7,09
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -100,00% | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0,0 | Net Income (TTM) | -303,27M |
| ROE | -45,83% | ROA | -32,33% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -249,12M |
| ROIC | -27,86% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,00 | Current Ratio | 10,22 |
| Interest Coverage | 0,00 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -20,54 | P/B Ratio | 7,09 |
| P/S Ratio | N/A | PEG Ratio | -0,68 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 6,23B | Enterprise Value | 5,87B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 0,0 | 8,55M | 2,45M | 0,0 | 0,0 |
| Net Income | -303,27M | -182,82M | -123,28M | -214,03M | -167,06M |
| EPS (Diluted) | -13,48 | -10,21 | -18,69 | -69,33 | -58,96 |
| Gross Profit | -140.000,0 | -143,86M | -84,32M | -154,44M | 0,0 |
| Operating Income | -326,20M | -200,17M | -126,37M | -214,99M | -167,33M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 937,91M | 483,11M | 87,95M | 115,13M | 292,75M |
| Total Liabilities | 59,77M | 37,66M | 18,28M | 39,02M | 41,94M |
| Shareholders' Equity | 878,14M | 445,45M | 69,67M | 76,11M | 250,81M |
| Total Debt | 110.000,0 | 1,37M | 2,50M | 3,50M | 4,31M |
| Cash & Equivalents | 357,33M | 215,37M | 81,30M | 61,62M | 138,70M |
| Current Assets | 610,91M | 404,37M | 84,88M | 110,84M | 287,41M |
| Current Liabilities | 59,77M | 37,55M | 15,75M | 34,35M | 38,43M |